Informative Video Before LMWH Postpartum - Randomized Controlled Trial

Condition(s) studied

Investigational drug(s) / intervention(s)

Informative Video on LMWH: A short (up to 5 minutes) informative video presented to postpartum women prior to their first LMWH (Clexane) injection. The video explains the rationale, process, and safety of LMWH use for thrombopr

Standard Verbal Explanation: Participants receive the routine verbal explanation regarding postpartum LMWH (Clexane) administration, covering its purpose and method of injection

Study summary

This single-center randomized controlled trial evaluates whether a short informative video can reduce anxiety and pain before the first postpartum administration of low molecular weight heparin (LMWH, Clexane). Eligible women will be randomized to receive either standard explanation alone or standard explanation plus a short educational video. The primary outcome is anxiety level assessed via the State-Trait Anxiety Inventory (STAI). Secondary outcomes include pain, satisfaction, and treatment adherence.

Eligibility

Primary outcome measure(s)

• Post-intervention Anxiety Level (STAI Score) — Immediately after intervention and before first LMWH injection
  Anxiety will be measured using the State-Trait Anxiety Inventory (STAI) after participants receive either the standard explanation alone or view informative video, and before their first LMWH (Clexane) injection.

Trial sites (1)

More Wolfson Medical Center trials in Israel

Other trials for the same condition